Search

everythinglearnresearchcommunity

for

Search:↓

Blocking CRF1 receptors improved male hormone levels and reduced testicular tumor size in men with a specific adrenal condition.

Early diagnosis and individualized treatment improve outcomes for Congenital Adrenal Hyperplasia.

Tofacitinib may effectively treat folliculitis decalvans.

Tofacitinib citrate is effective for moderate-to-severe chronic plaque psoriasis but has safety concerns at higher doses.

Tildrakizumab significantly improved recalcitrant lichen planopilaris and frontal fibrosing alopecia.

Tofacitinib helped a woman regrow her hair without relapses after other treatments failed.

Topical tofacitinib helped a man with severe scalp condition after other treatments failed.

Tofacitinib effectively treated both ulcerative colitis and alopecia areata in two patients.

Tretinoin cream successfully treated a woman's skin condition called Fox-Fordyce disease.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Tofacitinib effectively regrows hair in alopecia areata patients, especially in younger individuals, with manageable side effects.

Tofacitinib helped regrow hair in a woman with alopecia areata.

Tofacitinib can help hair grow back in alopecia patients but hair loss might return if the dose is lowered.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.

Topical tofacitinib cream may help treat certain hair loss conditions with fewer risks.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Tofacitinib partially improved hair regrowth in a patient with severe hair loss.

Tofacitinib may help regrow hair in alopecia areata patients.

Tofacitinib treatment for hair loss may worsen acne.

Tofacitinib citrate improved nail dystrophy and pain in patients with alopecia universalis without causing side effects.

Tofacitinib taken by mouth helps treat hair loss in children.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

Tofacitinib shows promise for treating severe alopecia areata with good safety and effectiveness.

Tofacitinib, a hair regrowth treatment, may worsen acne.

Tofacitinib successfully treated hair loss in a Crohn's disease patient who previously used adalimumab.

Tofacitinib treatment significantly improved a patient's psoriasis, psoriatic arthritis, and alopecia universalis.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

Tofacitinib is effective and safe for elderly patients with ulcerative colitis.

The trial showed that a new under-the-tongue treatment for severe hair loss was somewhat effective in a small group of people.

Tofacitinib helped regrow hair in a patient with severe hair loss and improved their quality of life without side effects.